Author:
Ussia Paolo,Cammalleri Valeria,Romeo Francesco
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference44 articles.
1. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-1836.;
2. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, Devarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, Delarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk Acute and Late Outcomes of the Multicenter Canadian Experience. J Am Coll Cardiol 2010.;
3. Piazza N, Grube E, Gerckens U, Den Heijer P, Linke A Luha O, Ramondo A.B., Ussia GP, Wenaweser P, Windecker S, Laborde J.C.,De Jaegere P, Serruys P.W: on the behalf of the clinical centres who actively participated in the registry. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded\evaluation registry 1-year following CE mark approval. EuroInterv 2008; 4: 242-249.;
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.;
5. Authors/Task Force Members, Vahanian A, Alfieri O, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2012;33:2451-2496.;